The Therapeutic Use of Cannabinoids: Forensic Aspects

Highlights • Nabiximols contains two of the main active cannabinoids. • We analyzed urine and blood samples from patients treated with Nabiximols. • The study was conducted on 20 patients (49-61 years) affected by Multiple Sclerosis. • The results allow affirming Nabiximols is not suitable as illici...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Forensic science international 2016-08, Vol.265, p.200-203
Hauptverfasser:	Indorato, Francesca, Liberto, Aldo, Ledda, Caterina, Romano, Guido, Barbera, Nunziata
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Inhalation Alcohol Analgesics, Non-Narcotic - administration & dosage Analgesics, Non-Narcotic - blood Analgesics, Non-Narcotic - therapeutic use Analgesics, Non-Narcotic - urine Biochemistry Blood Blood concentration Cannabidiol - administration & dosage Cannabidiol - blood Cannabidiol - therapeutic use Cannabidiol - urine Cannabinoid Cannabinoids - administration & dosage Cannabinoids - blood Cannabinoids - therapeutic use Cannabinoids - urine Confidence intervals Dronabinol - administration & dosage Dronabinol - blood Dronabinol - therapeutic use Dronabinol - urine Drug Combinations Drug dosages Drugs Female Forensic engineering Forensic sciences Forensic Toxicology Formulations Habits Humans Laboratories Male Marijuana Markets Middle Aged Multiple Sclerosis Nabiximols Pain, Intractable - drug therapy Pathology Patients Studies Temperature Therapeutic use Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • Nabiximols contains two of the main active cannabinoids. • We analyzed urine and blood samples from patients treated with Nabiximols. • The study was conducted on 20 patients (49-61 years) affected by Multiple Sclerosis. • The results allow affirming Nabiximols is not suitable as illicit drug.
ISSN:	0379-0738 1872-6283
DOI:	10.1016/j.forsciint.2016.03.031